|Mr. Marcos Agramont||CEO & Director||N/A||N/A||N/A|
|Mr. Patrick Edward Ogle J.D., L.L.M.||COO & Director||N/A||N/A||N/A|
|Mr. Marvin Washington||VP & Director of Bus. Devel. and Director||N/A||N/A||N/A|
|Mr. Soheil Samimi||Advisor||N/A||N/A||N/A|
|Mr. Andrew S. Alvis||Pres, Interim CFO & Director||N/A||N/A||N/A|
Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.
Isodiol International Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.